IMA Q2 2023 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+424.6% YoY

Gross Profit

-$12M-608.0% margin

Operating Income

-$18M-922.7% margin

Net Income

-$17M-854.0% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

-62.3%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$172M

Total Liabilities

$15M

Stockholders' Equity

$157M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$382,000	+424.6%
Gross Profit	-$12M	-$15M	+19.3%
Operating Income	-$18M	-$21M	+11.7%
Net Income	-$17M	-$20M	+16.5%